Home › Atrial Fibrillation › New Jersey › Trenton
Atrial Fibrillation clinical trials in Trenton, NJ
4 studies for Atrial Fibrillation are looking for participants at sites in and around Trenton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
RecruitingPhase 3
- Cardiology Consultants of Philadelphia (CCP), Yardley · 6 mi away
PULSED AF Post-Approval Study
RecruitingObservational study
- Doylestown Health Cardiology a division of Doylestown Health Physicians, Doylestown · 21 mi away
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Recruiting
- Capital Health Regional Medical Center, Trenton
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- Advanced Heart and Vascular Institute of Hunterdon, Flemington · 21 mi away
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- Boston, MA19 studies
- New York City, NY19 studies
- Atlanta, GA17 studies
- Cleveland, OH17 studies
- Jonesboro, AR13 studies
- Pittsburgh, PA12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI12 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Cincinnati, OH10 studies
- Austin, TX10 studies
Other studies in Trenton
- Breast Cancer11 studies
- Psoriasis7 studies
- Cardiovascular Disease7 studies
- Heart Failure7 studies
- Type 2 Diabetes6 studies
- Obesity5 studies
- Ovarian Cancer5 studies
- Non-Small Cell Lung Cancer4 studies
- Colorectal Cancer4 studies
- High Blood Pressure4 studies
- Cancer (all types)4 studies
- Triple-Negative Breast Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.